Pay in 4 interest-free payments of $5.31 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Impacts especially show up at microscopic doses of these meds
Sociodemographic disparities in GLP-1RA and SGLT2i use among US adults with type 2 diabetes: NHANES 2005-March 2020
I feel like that's what kind of gave it initially the bad rap
PDC is calculated as (number of days covered) / (total days in the time period) Cohorts and Time Horizons The second phase of analysis extends and refines the original analysis by separating cohorts by primary indication: Diabetes cohort: Individuals with a diabetes indication and GLP-1 use primarily for glycemic control Weight loss cohort: Individuals using GLP-1s for obesity or weight management without a diabetes indication Extending observation periods 30-month analysis window for the diabetes cohort 18-month analysis window for the weight loss cohort This approach allows us to evaluate whether the cost and clinical trends seen in the first white paper persist over a longer timeframe and whether they hold consistently across key sub populations
US$ 22.81
US$ 22.73
.png)
US$ 21.14
US$ 23.77
US$ 23.16
US$ 20.89
US$ 27.18
